The non-neuronal cyclin-dependent kinase 5 is a fibrotic mediator potentially implicated in systemic sclerosis and a novel therapeutic target
Jun Wei(Northwestern University), John Varga(Michigan Medicine)
Cited by 14
Related Papers
Systemic sclerosis: a prototypic multisystem fibrotic disorder
|Journal of Clinical Investigation|2007|1.1k
Rosiglitazone Abrogates Bleomycin-Induced Scleroderma and Blocks Profibrotic Responses Through Peroxisome Proliferator-Activated Receptor-γ
|American Journal Of Pathology|2009|227
Targeted Disruption of TGF-β/Smad3 Signaling Modulates Skin Fibrosis in a Mouse Model of Scleroderma
|American Journal Of Pathology|2004|213
Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: A novel mouse model for scleroderma?
|Arthritis & Rheumatism|2011|211